PRINCETON N.J. Feb. 6 2012 PRNewswire Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicati...
↧